Psychiatry and Neurology, Neurology · Miami, FL
NPI
1295998441
Since 2008
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1120 NW 14th St
Miami, FL, 33136
Phone (305) 243-4658
Groups this clinician bills Medicare through
Medicare paid, 2024
$20K
198 services
Medicare patients, 2024
135
Average age 65
Drug cost, 2024
$1.5M
1,549 prescriptions
Company payments, 2025
$32K
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kamil Detyniecki was code 95819 (neurologic), 36 times for 35 patients. In total Kamil Detyniecki billed 198 services in 21 codes, and Medicare paid $20K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-09-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95819 Neurologic | Facility | 36 | 35 | $45.93 | $1,653 |
| 99214 Office E&M - Established | Office | 36 | 30 | $96.94 | $3,490 |
| 95720 Neurologic | Facility | 30 | 15 | $173.56 | $5,207 |
| 95816 Neurologic | Facility | 15 | 15 | $45.93 | $689 |
| 99213 Office E&M - Established | Office | 15 | 14 | $50.77 | $762 |
By year: 2022 $38K for 321 services; 2023 $45K for 375 services; 2024 $20K for 198 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kamil Detyniecki prescribed most often to Medicare patients was Lamotrigine, with 156 prescriptions and refills. In total Kamil Detyniecki wrote 1,549 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lamotrigine Generic | 156 | 325 | 35 | $2,588 |
| Xcopri Cenobamate | 135 | 139 | 16 | $192K |
| Levetiracetam Generic | 122 | 278 | 36 | $8,421 |
| Clonazepam Generic | 86 | 86 | 17 | $915 |
| Vimpat Lacosamide | 79 | 83 | Under 11 | $96K |
| Divalproex Sodium Er Divalproex Sodium | 74 | 180 | 21 | $3,993 |
| Lacosamide Generic | 69 | 79 | 18 | $16K |
| Clobazam Generic | 66 | 72 | 13 | $4,776 |
| Epidiolex Cannabidiol (Cbd) | 59 | 59 | Under 11 | $293K |
| Topiramate Generic | 53 | 87 | 12 | $5,583 |
| Lamictal Lamotrigine | 53 | 95 | 12 | $86K |
| Divalproex Sodium Generic | 43 | 78 | Under 11 | $3,064 |
| Oxcarbazepine Generic | 38 | 82 | Under 11 | $2,998 |
| Aptiom Eslicarbazepine Acetate | 34 | 36 | Under 11 | $90K |
| Keppra Levetiracetam | 29 | 61 | Under 11 | $75K |
Brand drugs: - claims; generic drugs: 940 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kamil Detyniecki $32K ($32K in general payments such as food, travel and fees) from 8 companies. The largest payer was UCB, Inc. with $22K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.